AI summary by TwinMind

Uğur Şahin and Özlem Türeci: Meet the scientist couple driving an mRNA vaccine revolution | TED

TED

24m 54s

Background and Meeting

  • Tommy (Uğur Şahin) and Özlem Türeci met on oncology/hematology ward
    • Tommy was young physician, Özlem in medical school training
    • Met in world of patient care treating oncohematology patients
    • Shared dilemma: limited treatment options for cancer patients despite promising lab technologies
    • Shared vision: bridge gap by bringing science/technology fast to patient bedside for high medical need

Early Company Formation and Marriage

  • First company founded ~20 years ago to use immune system against cancer
  • As immunologists, knew power of human immune system but it didn't fight cancer cells naturally
  • Wanted to develop immunotherapies to redirect immune system to cancer cells
  • University setting inadequate for monoclonal antibody development
    • Cost: 20-30 million euros before clinical trials
  • Founded company to secure funding
  • Wedding: well-planned quick ceremony, returned to laboratory afterward
    • Guests were research team members
    • "No time to lose" mentality

Work-Life Integration Philosophy

  • Don't differentiate between work and life balance
  • Consider being scientists a privilege
  • Combine normal life with professional life seamlessly
  • Love what they do as "true scientists"

mRNA Technology Development

  • mRNA: natural molecule, one of first small molecules of life
  • Carrier of genetic information, unlike DNA it's not stable
  • Can transfer information to human cells to build therapeutic proteins
    • Vaccine proteins
    • Antibodies
    • Other drug proteins
  • Key advantage: can be produced within few days
  • Fascinated by speed for personalized cancer medicines
  • Cancer treatment challenge: every patient has different tumor
    • Similarity between two patients' same tumor type: <3%
    • 97% is unique to individual patient
  • Sought technology for personalized immunotherapy within shortest possible time
  • Get genetic sequence of tumor, make personalized vaccine within few weeks

mRNA as Universal Platform

  • DNA like library/Oxford English Dictionary (reference)
  • mRNA does actual living work (like language in use)
  • Platform can deliver any type of message to body cells
  • Versatile: can deliver protein blueprints and instructions
  • Can design into mRNA:
    • What protein to produce
    • How protein should be built
    • Instructions to protein factories
    • Control protein amounts and duration
    • Define pharmacokinetics in cells

COVID-19 Vaccine Development Timeline

  • End January 2020: read paper about Wuhan outbreak
  • Realized features indicated global pandemic potential
  • Concerned about life changes and mankind's fate
  • Had mRNA technology developed for personalized cancer therapy
  • Similar situation: genetic information available (virus sequence released 2 weeks earlier)
  • Task: make vaccine as fast as possible
  • Challenge: almost nothing known about completely new virus
  • Target selection: spike protein on virus surface
    • 20-25-30 spike proteins per virus
    • Two functions: enables virus to stick to human cells (lung), acts as key for cell entry
  • Goal: engineer immune response against spike protein

Vaccine Mechanism and Results

  • mRNA nanoparticles encapsulated in lipids
  • Delivered specifically to lymph nodes, not just anywhere
  • Reaches dendritic cells (immune system coaches/generals)
  • Dendritic cells train different special forces on "wanted poster"
  • Animal model results: lymph node comparison
    • Left side: no RNA treatment
    • Right side: RNA vaccination showing many red dots (T cells)
    • T cells trained to recognize antigen, expanded to army of clones
    • All focused on attacking specific mRNA-encoded protein

Clinical Trial Results

  • Sunday when waiting for results from independent committee
  • Uncertain whether thumbs up or down
  • Relief and joy: vaccine highly efficacious >90%
  • Protection against severe infection and fatalities almost complete
  • Sunday evening: handful of people knew effective vaccine existed
  • Shared information next day

Future Pandemic Preparedness

  • Current challenge: insufficient production capacity
  • Need for next pandemic: develop AND manufacture/distribute at light speed
  • Requirement: idle manufacturing capacity
  • Goal: produce 12 billion doses (considering prime-boost) within <6 months
  • Technically possible with government/international investment
  • Need standardized plan/process for faster response
  • Potential: vaccine development and distribution start in <8 months

Cancer and Other Disease Applications

  • Now have approved technology and first approved product
  • COVID vaccine demonstrates mRNA power and safety
  • Opens door for new technology and molecule types
  • Current cancer pipeline: >10 products in clinical development
    • Diverse against different cancer types
  • Confident infectious disease success will continue with cancer immunotherapies
  • Revolutionary vs traditional drugs:
    • Traditional drugs change chemical environment of body area
    • mRNA allows specific, precise interventions
  • Potential next revolution in bio-pharma landscape
  • Disease as disturbed cell communication
  • Example: autoimmune disease (immune cells attacking normal cells)
  • Could engineer mRNA therapies to teach immune system to stop specific attacks
  • Precise communication with problem cells without inhibiting whole immune system

Company Transformation and Wealth

  • Company value rocketed, both now billionaires
  • "Too much money never a problem" - innovation requires investment
  • Prevents only me-too products or incremental improvements
  • Beginning 2020: product candidates in clinical testing but required regular funding
  • Now: can address full company vision at larger, broader scale
  • Bring innovations faster to patients
  • Vision: provide novel treatments wherever high unmet medical need exists

Immigration and Diversity Impact

  • Both from families who immigrated from Turkey to Germany
  • May have helped transform immigration debate in Germany through success
  • Surprised by attention to their background
  • Science approach: don't ask where person comes from, but what they can contribute
  • Company employees from >60 countries
  • International group of scientists like any research institution
  • Globalization helps bring scientists/engineers together for extraordinary results
  • Consider this normal way excellent research and science works

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome